EEF2 anticorps (N-Term)
Aperçu rapide pour EEF2 anticorps (N-Term) (ABIN630891)
Antigène
Voir toutes EEF2 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Specificité
- EEF2 antibody was raised against the N terminal of EEF2
-
Purification
- Affinity purified
-
Immunogène
- EEF2 antibody was raised using the N terminal of EEF2 corresponding to a region with amino acids TDSLVCKAGIIASARAGETRFTDTRKDEQERCITIKSTAISLFYELSEND
-
-
-
-
Indications d'application
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
EEF2 Blocking Peptide, (ABIN5613309), is also available for use as a blocking control in assays to test for specificity of this EEF2 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of EEF2 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- EEF2 (Eukaryotic Translation Elongation Factor 2 (EEF2))
-
Autre désignation
- EEF2
-
Sujet
- EEF2 is a member of the GTP-binding translation elongation factor family. The protein is an essential factor for protein synthesis. It promotes the GTP-dependent translocation of the nascent protein chain from the A-site to the P-site of the ribosome. This protein is completely inactivated by EF-2 kinase phosporylation.
-
Poids moléculaire
- 94 kDa (MW of target protein)
-
Pathways
- AMPK Signaling
Antigène
-